Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMA
Comerica
CMA
|
+$221M |
| 2 |
RSPP
RSP Permian, Inc.
RSPP
|
+$166M |
| 3 |
Vulcan Materials
VMC
|
+$165M |
| 4 |
ANDV
Andeavor
ANDV
|
+$165M |
| 5 |
Apple
AAPL
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$251M |
| 2 |
Bank of America
BAC
|
+$225M |
| 3 |
WOOF
VCA Inc.
WOOF
|
+$214M |
| 4 |
K
Kellanova
K
|
+$188M |
| 5 |
Occidental Petroleum
OXY
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.61% |
| 2 | Technology | 11.6% |
| 3 | Healthcare | 11.38% |
| 4 | Energy | 10.68% |
| 5 | Industrials | 10.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRA
326
DELISTED
W.R. Grace & Co.
GRA
| $47.5M | 0.09% |
680,782
+172,131
| +34% | +$12.1M |
|
327
Teva Pharmaceuticals
TEVA
$43.5B
| $47.3M | 0.09% |
1,474,988
+1,367,636
| +1,274% | +$46.7M |
|
328
Biogen
BIIB
$32B
| $47M | 0.09% |
171,739
-315,771
| -65% | -$89.3M |
|
329
Cullen/Frost Bankers
CFR
$10.2B
| $47M | 0.09% |
527,752
+245,286
| +87% | +$22.1M |
|
330
General Mills
GIS
$21.4B
| $46.9M | 0.09% |
794,485
-23,238
| -3% | -$1.42M |
|
331
LyondellBasell Industries
LYB
$21.8B
| $46.7M | 0.09% |
512,288
+450,373
| +727% | +$41.1M |
|
332
Blackrock
BLK
$179B
| $46.5M | 0.09% |
+121,213
| New | +$46.4M |
|
|
HRC
333
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $46.2M | 0.08% |
654,681
-659,707
| -50% | -$42M |
|
334
Oracle
ORCL
$422B
| $45.9M | 0.08% |
1,027,887
+1,018,491
| +10,840% | +$42.4M |
|
335
Humana
HUM
$45.5B
| $45.7M | 0.08% |
221,661
+174,901
| +374% | +$36.2M |
|
336
Tapestry
TPR
$26B
| $45.7M | 0.08% |
1,105,149
+510,922
| +86% | +$19.3M |
|
337
Fidelity National Information Services
FIS
$21.3B
| $45.5M | 0.08% |
571,186
-703,270
| -55% | -$56.6M |
|
338
Johnson & Johnson
JNJ
$651B
| $45.3M | 0.08% |
363,898
+350,398
| +2,596% | +$41.9M |
|
339
Celanese
CE
$5.14B
| $45.2M | 0.08% |
503,097
-259,931
| -34% | -$22.7M |
|
|
PDS
340
Precision Drilling
PDS
$1.18B
| $45.1M | 0.08% |
477,982
+176,616
| +59% | +$18.5M |
|
341
Travelers Companies
TRV
$75.8B
| $45.1M | 0.08% |
+374,129
| New | +$45M |
|
342
Tronox
TROX
$888M
| $44.7M | 0.08% |
2,424,781
+1,059,284
| +78% | +$15.7M |
|
343
Revvity
RVTY
$13.9B
| $44.7M | 0.08% |
769,512
+439,692
| +133% | +$24M |
|
344
Macy's
M
$6B
| $44.5M | 0.08% |
1,501,300
+427,013
| +40% | +$13.2M |
|
345
Jabil
JBL
$32.8B
| $44.5M | 0.08% |
1,538,625
+327,910
| +27% | +$8.39M |
|
346
Carlisle Companies
CSL
$14.6B
| $44.1M | 0.08% |
414,059
+98,945
| +31% | +$10.6M |
|
|
CDK
347
DELISTED
CDK Global, Inc.
CDK
| $44M | 0.08% |
676,790
+609,554
| +907% | +$39M |
|
348
Varex Imaging
VREX
$780M
| $43.9M | 0.08% |
+1,307,524
| New | +$41.4M |
|
|
NUVA
349
DELISTED
NuVasive, Inc.
NUVA
| $43.9M | 0.08% |
587,226
+244,394
| +71% | +$17.7M |
|
350
Henry Schein
HSIC
$9.86B
| $43.7M | 0.08% |
656,133
-19,020
| -3% | -$1.24M |
|
Similar funds
Israel Englander's Q1 2017 Portfolio in Review
As of Q1 2017, Israel Englander held 4,184 positions worth $54.6B, up 14% from $47.8B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
Israel Englander deployed $4.44B of net new capital in Q1 2017, opening 894 new positions and adding to 1,327 existing holdings. Its largest new stake was Mondelez International: 3,261,215 shares worth $140M.
By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bank of New York Mellon, an estimated $251M trimmed.
- Israel Englander's largest Q1 2017 buy was Mondelez International: 3,261,215 shares worth $140M.
- Israel Englander added most to Comerica in Q1 2017, an estimated $221M increase.
- Israel Englander's biggest Q1 2017 reduction was Bank of New York Mellon, cutting an estimated $251M.
- Israel Englander fully exited Occidental Petroleum in Q1 2017, selling an estimated $171M.
- Israel Englander's ten largest holdings make up 5.7% of its $54.6B portfolio in Q1 2017.
- Israel Englander opened 894 new positions and closed 743 in Q1 2017.
- Israel Englander's portfolio value rose 14% quarter-over-quarter to $54.6B.
Based on Millennium Management's 13F filing for Q1 2017, filed 15 May 2017.